https://medness.org/brainvectis-receives-clearance-to-conduct-phase-i-ii-clinical-trial-for-early-stage-huntingtons-disease/2022-09-07T12:34:08+00:00https://medness.org/submission-of-new-drug-application-to-the-fda-for-the-treatment-of-parkinsons-disease/2025-09-24T18:13:44+00:00https://medness.org/amydis-receives-nih-grant-award-to-develop-a-novel-tdp-43-retinal-tracer-for-als-patients%ef%bf%bc/2022-09-07T12:43:43+00:00https://medness.org/phase-2a-clinical-trial-data-for-coya-101-in-als-announced/2022-09-07T12:40:19+00:00https://medness.org/ab-science-submits-application-to-ema-for-conditional-marketing-of-masitinib-for-the-treatment-of-als/2022-09-07T12:49:25+00:00https://medness.org/new-recommendations-for-influenza-vaccine-composition/2022-11-04T11:55:28+00:00https://medness.org/recommendations-of-the-advisory-committee-on-pneumococcal-immunization-practices/2022-11-04T11:54:57+00:00https://medness.org/chronic-oral-dosage-of-ht-alz-improves-spatial-memory-in-mouse-model-of-alzheimers-disease/2025-09-24T18:12:58+00:00https://medness.org/fda-clears-roches-elecsys-csf-diagnosis-assays-for-alzheimers-disease/2025-09-24T18:17:54+00:00https://medness.org/leqembi-approved-by-fda-for-early-alzheimers-disease-treatment/2025-09-24T18:12:05+00:00https://medness.org/lilys-donanemab-poised-for-fdas-approval/2025-09-24T18:17:11+00:00https://medness.org/lack-of-ethnic-diversity-in-alzheimers-disease-clinical-trials-how-patients-of-color-getside-lined/2025-09-23T22:46:03+00:00https://medness.org/wavebreaks-small-molecule-inhibits-toxic-oligomers-of-alpha-synuclein-in-pre-clinical-study/2025-09-24T18:16:31+00:00https://medness.org/cancer-early-diagnosis-and-liquid-biopsies-are-we-there-yet/2025-09-23T01:45:09+00:00https://medness.org/guardant-health-in-liquid-biopsy-cancer-diagnosis/2025-09-23T01:43:20+00:00https://medness.org/neurosense-receives-patent-approval-for-als-candidate-drug-primec-from-multiple-countries/2025-09-24T18:15:56+00:00https://medness.org/abbvie-acquires-mitokinin-in-its-neuroscience-pipeline/2025-09-24T18:15:15+00:00https://medness.org/nateras-successful-evolution-in-molecular-diagnostics/2025-09-23T01:39:17+00:00https://medness.org/aquinnahs-potential-alzheimers-drug-capable-of-reducing-70-brain-tau-pathology/2025-09-24T18:14:26+00:00https://medness.org/exact-sciences/2025-09-23T01:35:07+00:00https://medness.org/foundation-medicine/2025-09-23T01:32:47+00:00https://medness.org/stempeers-oncology-digital-news-aggregator-platform-onco-this-week-acquired-by-rosenblatt-life-science-consultants/2024-02-10T04:49:49+00:00https://medness.org/epcam-car-t-therapy-receives-dual-ind-from-u-s-fda-and-china-cde/2025-09-23T01:31:00+00:00https://medness.org/care-for-rare-celebrating-rare-disease-day/2025-09-23T01:30:07+00:00https://medness.org/versatile-zepbound-by-eli-lilly-became-the-first-weight-loss-drug-approved-by-the-fda/2025-09-24T18:18:32+00:00https://medness.org/fda-approval-of-amivantamab-vmjw-advancing-treatment-for-egfr-exon-20-insertion-mutated-non-small-cell-lung-cancer/2025-09-23T01:17:42+00:00https://medness.org/care-for-rare-prologue/2025-09-23T01:15:57+00:00https://medness.org/personal-genome-diagnostics/2025-09-23T01:15:02+00:00https://medness.org/a-for-acromegaly-part-i/2025-09-23T01:11:54+00:00https://medness.org/fda-approves-inotuzumab-ozogamicin-for-pediatric-acute-lymphoblastic-leukemia/2025-09-23T01:13:35+00:00https://medness.org/a-for-acromegaly-part-ii/2025-09-23T23:10:37+00:00https://medness.org/novo-weight-loss-drug-semaglutide-ozempics-reduces-kidney-disease-progression/2024-03-20T22:42:18+00:00https://medness.org/takedas-iclusig-receives-fda-approval-for-frontline-treatment-of-ph-acute-lymphoblastic-leukemia/2024-03-20T21:19:00+00:00https://medness.org/b-for-beta-thalassemia/2025-09-23T23:42:41+00:00https://medness.org/advancing-cancer-treatment-fda-approval-of-mirvetuximab-soravtansine-gynx-for-platinum-resistant-epithelial-ovarian-cancer/2025-09-23T23:41:08+00:00https://medness.org/b-for-beta-thalassemia-part-ii/2025-09-23T23:43:02+00:00https://medness.org/supplemental-biologics-license-application-for-intravenous-maintenance-dosing-of-alzheimers-drug-leqembi/2025-09-23T22:48:27+00:00https://medness.org/wegovy-is-the-new-weight-loss-superstar-to-win-fda-approval/2025-09-23T23:18:09+00:00https://medness.org/c-for-crigler-najjar-syndrome/2025-09-23T23:52:35+00:00https://medness.org/accelerated-approval-granted-to-enhertu-for-her2-positive-solid-tumors/2025-09-23T23:40:38+00:00https://medness.org/mission-therapeutics-starts-a-clinical-trial-on-its-parkinsons-disease-lead-mtx325/2025-09-23T22:47:10+00:00https://medness.org/advancing-alzheimers-disease-diagnosis/2025-09-23T23:40:17+00:00https://medness.org/c-for-crigler-najjar-syndrome-part-ii/2025-09-23T23:52:17+00:00https://medness.org/d-for-duchenne-muscular-dystrophy-part-i/2025-09-23T23:51:18+00:00https://medness.org/fda-approval-of-nogapendekin-alfa-inbakicept-pmln-a-breakthrough-in-bladder-cancer-treatment/2025-09-23T23:39:10+00:00https://medness.org/exciting-leadership-change-announcement/2024-04-24T20:39:22+00:00https://medness.org/the-us-fda-approves-lutetium-lu-177-dotatate-for-pediatric-patients-with-gep-nets/2025-09-23T23:38:50+00:00https://medness.org/d-for-duchenne-muscular-dystrophy-part-ii/2025-09-23T23:51:03+00:00https://medness.org/lixisenatide-has-added-benefits-for-treating-parkinson-disease/2025-09-23T23:16:58+00:00https://medness.org/accelerated-approval-of-tovorafenib-for-pediatric-low-grade-glioma-a-breakthrough-in-braf-altered-therapy/2025-09-23T23:38:22+00:00https://medness.org/e-for-erdheim-chester-disease-part-1/2025-09-23T23:50:47+00:00https://medness.org/sanofi-novavax-partner-on-covid-19-and-flu-combination-vaccines/2025-09-23T23:37:48+00:00https://medness.org/e-for-erdheim-chester-disease-part-ii/2025-09-23T23:50:30+00:00https://medness.org/f-for-fanconi-anemia/2025-09-23T23:48:12+00:00https://medness.org/fda-grants-accelerated-approval-to-tarlatamab-dlle-for-es-sclc/2025-09-23T23:37:28+00:00https://medness.org/follicular-lymphoma-treatment-option-gains-fda-approval-lisocabtagene-maraleucel/2025-09-23T23:37:07+00:00https://medness.org/fanconi-anemia-part-ii/2025-09-23T23:47:56+00:00https://medness.org/insulin-efsitora-alfa-substitute-for-continual-insulin-administration/2025-09-23T22:58:13+00:00https://medness.org/g-for-gaucher-disease-part-i/2025-09-23T23:47:42+00:00https://medness.org/us-fda-approves-breyanzi-for-relapsed-or-refractory-mantle-cell-lymphoma/2025-09-23T23:36:33+00:00https://medness.org/gaucher-disease-part-ii/2025-09-23T23:47:18+00:00https://medness.org/fda-greenlights-mresvia-modernas-breakthrough-in-rsv-prevention/2025-09-24T00:06:00+00:00https://medness.org/eyeing-a-brighter-future-two-new-biosimilars-approved-for-macular-edema/2025-09-24T00:06:36+00:00https://medness.org/fda-grants-accelerated-approval-to-repotrectinib-for-ntrk-fusion-positive-tumors/2025-09-23T23:35:15+00:00https://medness.org/h-for-huntingtons-disease-part-i/2025-09-23T23:46:52+00:00https://medness.org/breaking-barriers-in-rare-disease-treatment-fda-approves-bkemv-as-first-interchangeable-biosimilar/2025-09-24T00:05:05+00:00https://medness.org/fda-approves-blinatumomab-as-consolidation-therapy-for-cd19-positive-philadelphia-chromosome-negative-b-cell-precursor-acute-lymphoblastic-leukemia/2025-09-23T23:34:58+00:00https://medness.org/iqirvo-clears-fda-hurdle-offering-new-relief-for-primary-biliary-cholangitis-patients/2025-09-24T00:04:46+00:00https://medness.org/h-for-huntingtons-disease-part-ii/2025-09-23T23:46:38+00:00https://medness.org/fda-grants-accelerated-approval-to-adagrasib-with-cetuximab-for-kras-g12c-mutated-colorectal-cancer/2025-09-23T23:34:28+00:00https://medness.org/i-for-i-cell-disease-part-i/2025-09-23T23:46:22+00:00https://medness.org/fda-grants-accelerated-approval-to-epcoritamab-bysp-for-relapsed-or-refractory-follicular-lymphoma/2025-09-23T23:34:04+00:00https://medness.org/i-for-i-cell-disease-part-ii/2025-09-23T23:45:49+00:00https://medness.org/forget-me-not-new-alzheimers-drug-from-eli-lilly-gets-fda-nod/2025-09-24T00:04:26+00:00https://medness.org/j-for-juvenile-cln3-disease/2025-09-23T23:45:28+00:00https://medness.org/mito-give-me-the-power-to-rejuvenate/2025-09-24T18:37:49+00:00https://medness.org/alkaline-phosphatase-potential-cure-for-acute-kidney-injury/2025-09-23T22:56:05+00:00https://medness.org/j-for-juvenile-cnl3-disease-part-ii/2025-09-23T23:45:07+00:00https://medness.org/merck-signs-mou-with-gene-therapy-research-institution-to-advance-gene-therapy-production/2025-09-23T23:33:33+00:00https://medness.org/slimmer-days-ahead-roches-new-obesity-drug-shows-potential/2025-09-23T23:09:34+00:00https://medness.org/fda-approves-daratumumab-and-hyaluronidase-fihj-combination-for-multiple-myeloma/2025-09-23T23:33:11+00:00https://medness.org/k-for-kennedy-disease-part-i/2025-09-23T23:44:51+00:00https://medness.org/a-ray-of-hope-islets-transplantation-for-t2d-patients-too/2025-09-23T23:08:31+00:00https://medness.org/k-for-kennedy-disease-part-ii/2025-09-23T23:44:35+00:00https://medness.org/fda-expands-endometrial-cancer-indication-for-dostarlimab-gxly-with-chemotherapy/2025-09-23T23:32:43+00:00https://medness.org/tasty-traps-fda-and-ftc-warn-against-copycat-snack-containing-delta-8-thc/2025-09-24T00:03:52+00:00https://medness.org/lets-mashup/2025-09-24T18:37:05+00:00https://medness.org/l-for-legg-calve-perthes-disease-part-i/2025-09-23T23:44:17+00:00https://medness.org/fda-grants-accelerated-approval-to-afamitresgene-autoleucel-for-unresectable-or-metastatic-synovial-sarcoma/2025-09-23T23:32:21+00:00https://medness.org/l-for-legg-calve-perthes-disease-part-ii/2025-09-23T23:53:54+00:00https://medness.org/fda-approves-neoadjuvant-adjuvant-durvalumab-for-resectable-nsclc/2025-09-23T23:31:03+00:00https://medness.org/m-for-multiple-myeloma-part-i/2025-09-23T23:54:14+00:00https://medness.org/your-face-can-predict-metabolic-disorders/2025-09-24T18:36:02+00:00https://medness.org/fda-approves-lazertinib-and-amivantamab-vmjw-combination-for-first-line-treatment-of-egfr-mutant-nsclc/2025-09-23T23:30:38+00:00https://medness.org/redefining-the-standard-of-care-lazertinib-and-amivantamab-for-nsclc/2025-09-24T00:03:20+00:00https://medness.org/m-for-multiple-myeloma-part-ii/2025-09-23T23:54:28+00:00https://medness.org/cahn-you-do-it/2025-09-23T23:07:46+00:00https://medness.org/precision-in-nsclc-treatment-the-predictive-power-of-trop2-qcs-in-datopotamab-deruxtecan-therapy/2025-09-23T23:30:12+00:00https://medness.org/n-for-narcolepsy-part-i/2025-09-23T23:54:44+00:00https://medness.org/once-weekly-insulins-show-promise-in-simplifying-diabetes-management/2025-09-23T22:59:43+00:00https://medness.org/n-for-narcolepsy-part-ii/2025-09-23T23:55:01+00:00https://medness.org/o-for-osteosarcoma-part-i/2025-09-23T23:55:17+00:00https://medness.org/nanotechnology-revolutionizing-diabetes-treatment-and-diagnostics/2025-10-14T22:12:56+00:00https://medness.org/transparent-mice-are-here-not-a-science-fiction-but-a-reality/2024-09-25T20:26:05+00:00https://medness.org/wegovy-expanding-benefits-for-obesity-related-heart-failure-with-preserved-ejection-fraction/2025-09-23T23:28:19+00:00https://medness.org/recent-fda-approvals-pack-double-punches-against-niemann-pick-disease-type-c/2025-09-24T00:02:22+00:00https://medness.org/o-for-osteosarcoma-part-ii/2025-09-23T23:55:31+00:00https://medness.org/first-ipsc-islet-transplantation-in-humans-proceed-with-caution/2025-09-23T23:03:28+00:00https://medness.org/nivolumab-approved-for-neoadjuvant-and-adjuvant-therapy-in-resectable-nsclc-a-new-horizon-for-lung-cancer-treatment/2025-09-23T23:27:56+00:00https://medness.org/p-for-progeria-part-i/2025-09-23T23:55:46+00:00https://medness.org/p-for-progeria-part-ii/2025-09-23T23:56:01+00:00https://medness.org/vyalev-approved-by-fda-for-advanced-stage-parkinsons-disease-patients/2025-09-23T22:44:56+00:00https://medness.org/blood-glucose-as-a-predictor-of-cardiovascular-events/2025-09-24T18:35:16+00:00https://medness.org/fda-approval-of-inavolisib-combination-therapy-for-pik3ca-mutated-hr-positive-her2-negative-breast-cancer/2025-09-23T23:27:36+00:00https://medness.org/q-for-q-fever/2025-09-23T23:56:19+00:00https://medness.org/fda-approves-zolbetuximab-clzb-for-advanced-gastric-and-gej-adenocarcinoma/2025-09-23T23:27:16+00:00https://medness.org/fda-certifies-vyloy-as-a-novel-approach-against-gastric-cancer-a-cldn18-2-targeted-therapy/2025-09-24T00:01:44+00:00https://medness.org/r-for-retinoblastoma-part-i/2025-09-23T23:13:58+00:00https://medness.org/r-for-retinoblastoma-part-ii/2025-09-23T23:21:35+00:00https://medness.org/amneal-pharmaceuticals-launches-crexont-a-combination-of-immediate-andextended-release-carbidopa-and-levodopa-for-parkinsons-disease/2025-09-23T22:39:43+00:00https://medness.org/a-non-invasive-biomarker-panel-for-mash/2025-09-24T18:33:55+00:00https://medness.org/fda-approves-obecabtagene-autoleucel-for-advanced-b-cell-acute-lymphoblastic-leukemia/2025-09-23T23:26:52+00:00https://medness.org/a-snapshot-of-worldwide-diabetes-prevalence-over-30-years-1990-2022/2025-09-24T18:31:12+00:00https://medness.org/s-for-sickle-cell-disease-part-i/2025-09-23T23:59:02+00:00https://medness.org/s-for-sickle-cell-disease-part-ii/2025-09-23T23:20:02+00:00https://medness.org/avoiding-sugars-in-the-first-1000-days-of-life-can-reduce-the-risk-of-type-2-diabetes-and-hypertension-in-your-60s-a-world-war-ii-sugar-rationing-study/2025-09-24T18:30:03+00:00https://medness.org/scientists-explained-why-you-gain-weight-quickly-after-stopping-dieting/2025-09-24T18:29:09+00:00https://medness.org/intermittent-fasting-can-cause-hair-loss-amid-all-the-health-gains/2025-10-03T01:57:46+00:00https://medness.org/expanding-global-access-to-mpox-vaccines-a-strategic-partnership-between-bavarian-nordic-and-serum-institute-of-india/2025-10-14T22:14:30+00:00https://medness.org/semaglutide-enhances-glycemic-control-with-automated-insulin-delivery-in-type-1-diabetes/2025-09-23T22:57:13+00:00https://medness.org/based-on-phase-3-trial-data-the-fda-approved-alhemo-for-the-treatment-of-hemophilia-related-bleeding/2025-09-24T00:00:54+00:00https://medness.org/shivering-can-make-you-healthy/2025-10-03T02:01:51+00:00https://medness.org/semaglutide-a-breakthrough-in-obesity-treatment/2025-09-23T23:23:36+00:00https://medness.org/diet-improving-gut-microbiome-provides-cardiometabolic-benefits/2025-09-23T23:00:24+00:00https://medness.org/anaphylaxis-alert-new-safety-concerns-emerge-for-glatiramer-acetate/2025-09-22T22:36:27+00:00https://medness.org/t-for-tay-sachs-disease/2025-09-22T22:02:20+00:00https://medness.org/over-exercise-leads-to-liver-fibrosis/2025-09-23T22:40:34+00:00https://medness.org/brentuximab-vedotin-combination-approved-for-relapsed-refractory-large-b-cell-lymphoma/2025-09-23T22:34:34+00:00https://medness.org/u-for-uveal-melanoma/2025-09-22T00:10:57+00:00https://medness.org/symbravo-a-fast-acting-dual-action-drug-to-relieve-migraine/2025-09-22T21:57:04+00:00https://medness.org/how-diet-coke-causes-atherosclerotic-plaque-mechanism-unlocked/2025-09-22T00:09:43+00:00https://medness.org/v-for-von-hippel-lindau-disease/2025-09-22T00:21:47+00:00https://medness.org/w-for-wilson-disease/2025-09-22T00:06:49+00:00https://medness.org/x-for-x-linked-protoporphyria/2025-09-22T00:09:14+00:00https://medness.org/gut-microbiota-and-its-metabolites-can-predict-anti-tumor-immunotherapy-efficacy/2025-09-22T00:05:20+00:00https://medness.org/y-for-yellow-fever/2025-09-22T00:08:12+00:00https://medness.org/orforglipron-an-oral-glp-1r-agonist-to-treat-type-2-diabetes/2025-09-22T00:04:02+00:00https://medness.org/z-for-zellweger-spectrum-disorders/2025-09-22T00:07:44+00:00https://medness.org/semaglutide-a-glp-1r-agonist-is-also-effective-for-mash-patients/2025-09-22T00:02:42+00:00https://medness.org/obsessive-compulsive-disorder-ocd/2025-10-09T02:50:34+00:00https://medness.org/first-fda%e2%80%91cleared-blood-test-for-alzheimers-amyloid-pathology-lumipulse-g-ptau-217-%ce%b2-amyloid-1-42-plasma-ratio/2025-10-06T23:28:51+00:00https://medness.org/obsessive-compulsive-disorder-ocd-treatment/2025-10-07T22:07:33+00:00https://medness.org/dual-payload-adcs-revolution-in-precision-oncology/2025-10-16T16:06:57+00:00https://medness.org/precision-power-against-cd30-adcetris-2/2025-10-27T21:39:08+00:00https://medness.org/adcs-the-precision-missiles-with-a-promising-future-in-cancer-treatment/2025-11-06T00:41:14+00:00https://medness.org/setting-the-stage-for-her2-adc-evolution-kadcyla/2025-10-16T16:06:26+00:00https://medness.org/advancing-precision-in-leukemia-besponsa/2025-10-27T21:39:43+00:00https://medness.org/schizophrenia/2025-11-20T21:51:06+00:00https://medness.org/biparatopic-design-engineering-the-next-gen-antibodies-for-adc-specific-functions/2025-10-23T15:30:10+00:00https://medness.org/schizophrenia-clinical-trials/2025-10-29T03:48:30+00:00https://medness.org/visby-medical-womens-sexual-health-test/2025-10-29T03:58:36+00:00https://medness.org/a-pioneers-journey-from-setback-to-resurgence-mylotarg/2025-10-30T22:24:30+00:00https://medness.org/flow-focus-introduction-to-the-series/2025-11-07T22:34:07+00:00https://medness.org/fat-or-carbs-how-brain-process-our-food-choices/2025-11-20T21:49:08+00:00https://medness.org/from-biparatopic-to-tetravalent-overcoming-the-next-frontier-in-adc-antibody-engineering/2025-11-06T01:09:27+00:00https://medness.org/pushing-the-boundaries-of-her2-therapy-enhertu/2026-01-03T23:46:04+00:00https://medness.org/flow-focus-a-flow-cytometry-technical-series/2026-01-03T23:46:20+00:00https://medness.org/first-in-class-precision-against-nectin-4-padcev/2026-01-03T23:45:32+00:00https://medness.org/bispecific-adcs-from-precise-to-ultra-precise/2026-01-03T23:45:11+00:00https://medness.org/experimental-design-instrument-first/2026-01-03T23:44:48+00:00https://medness.org/powering-precision-through-combination-therapy-polivy/2025-11-20T20:31:37+00:00https://medness.org/site-specific-conjugation-the-chemistry-quietly-powering-next-generation-adcs/2025-11-20T20:33:43+00:00https://medness.org/how-do-our-neural-networks-respond-to-mental-exhaustion/2025-11-20T20:38:19+00:00https://medness.org/experimental-design-c-antibody-selection/2025-11-20T20:40:10+00:00https://medness.org/the-evolution-of-adc-linkers-timers-and-triggers-for-precision-therapy/2026-01-03T23:43:39+00:00https://medness.org/self-immolative-and-traceless-linkers-how-chemistry-turned-one-antibody-into-multiple-blockbusters/2026-01-03T23:43:28+00:00https://medness.org/oncomine-dx-express-test/2026-01-03T23:42:21+00:00https://medness.org/leading-the-adc-breakthrough-in-tnbc-trodelvy/2026-01-03T23:42:37+00:00https://medness.org/self-immolative-and-traceless-linkers-how-chemistry-turned-one-antibody-into-multiple-blockbusters-2/2026-01-03T23:43:07+00:00https://medness.org/section-1-experimental-design/2026-01-03T23:41:53+00:00https://medness.org/tme-activated-linkers-giving-adcs-spatial-intelligence/2026-01-03T23:41:33+00:00https://medness.org/defining-key-flow-cytometry-terms/2026-03-25T17:09:42+00:00https://medness.org/bipolar-disorder/2026-01-03T23:41:03+00:00https://medness.org/how-early-brain-inflammation-and-immune-changes-shape-parkinsons-disease/2026-01-03T23:40:52+00:00https://medness.org/why-is-regulatory-affairs-needed-in-medical-devices/2026-01-03T23:40:34+00:00https://medness.org/sola-dosis-facit-venenum-a-history-of-use-and-misuse-of-a-toxin/2025-12-19T02:41:40+00:00https://medness.org/non-internalizing-acds-targeting-the-tumor-microenvironment-itself/2026-01-03T23:40:11+00:00https://medness.org/sola-dosis-facit-venenum-a-history-of-use-and-misuse-of-a-toxin-2/2025-12-25T03:08:57+00:00https://medness.org/how-ocular-fluids-reflect-alzheimers-disease-pathology/2026-01-03T23:38:26+00:00https://medness.org/bipolar-disorder-pharmacological-targets/2026-01-03T23:39:50+00:00https://medness.org/powering-next-gen-payload-innovation-zynlonta/2026-01-08T21:04:44+00:00https://medness.org/dual-payload-adcs-revisited-when-does-a-second-warhead-really-help/2026-01-08T21:08:27+00:00https://medness.org/why-wearables-need-rules-a-simple-guide-to-regulatory-affairs-in-health-tech/2026-01-09T05:04:32+00:00https://medness.org/ventana-sp44-rxdx-assay/2026-01-14T23:45:48+00:00https://medness.org/section-1-experimental-design-chapter-5-controls-and-replicates/2026-03-25T17:12:53+00:00https://medness.org/daily-supplements-is-your-brain-safe/2026-01-15T00:01:22+00:00https://medness.org/case-studies-for-remote-monitoring-devices/2026-01-15T00:12:04+00:00https://medness.org/dissociative-identity-disorder/2026-01-22T17:33:29+00:00https://medness.org/section-1-experimental-design-fpilot-runs-and-panel-optimization/2026-03-25T17:13:07+00:00https://medness.org/charting-new-territory-with-a-novel-tf-target-tivdak/2026-02-06T04:42:56+00:00https://medness.org/idylla-cdx-msi-test/2026-02-06T04:38:57+00:00https://medness.org/the-new-horizon-with-stem-cell/2026-02-06T04:35:47+00:00https://medness.org/fc-glycan-directed-adcs-the-platform-behind-the-headlines/2026-02-26T14:35:21+00:00https://medness.org/hiv-capsid-and-lenacapavir-a-breakthrough-in-hiv-treatment/2026-02-26T16:16:14+00:00https://medness.org/anxiety-disorder-generalized-anxiety-disorder/2026-02-26T14:42:43+00:00https://medness.org/can-digital-health-reduce-healthcare-inequality-or-widen-it/2026-02-26T17:57:53+00:00https://medness.org/1-experimental-designg-scaling-up/2026-03-25T17:13:20+00:00https://medness.org/opening-a-new-era-for-gynecologic-cancers-elahere/2026-03-06T04:38:00+00:00https://medness.org/generalized-anxiety-disorder-clinical-trials/2026-03-06T04:36:20+00:00https://medness.org/allocord-life-saver/2026-03-11T17:40:59+00:00https://medness.org/defining-key-flow-cytometry-terms-part-2/2026-03-11T17:48:53+00:00https://medness.org/from-monotherapy-to-backbone-how-adcs-are-anchoring-first-line-treatment/2026-03-20T14:02:16+00:00https://medness.org/beyond-cytotoxins-immunostimulatory-and-non-cytotoxic-payloads-in-adc-design/2026-03-25T17:49:17+00:00https://medness.org/2-sample-preparation-a-sample-collection/2026-03-25T17:48:46+00:00https://medness.org/nav1-8-and-suzetrigine/2026-03-25T22:48:53+00:00https://medness.org/guardant360-cdx/2026-04-03T02:37:45+00:00https://medness.org/2-sample-preparation-b-sample-storage/2026-04-03T02:35:14+00:00https://medness.org/antibody-oligonucleotide-conjugates-when-the-payload-is-a-gene-silencer/2026-04-09T13:56:07+00:00https://medness.org/a-shared-network-pattern-in-major-depressive-and-bipolar-depression-disorder/2026-04-09T14:04:19+00:00https://medness.org/section-2-sample-preparation/2026-04-23T16:29:46+00:00